Relevium Medical
PrivateLast Round
Grant
Nov 27, 2024
Total Funding Raised
$21.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Relevium Medical is a biopharmaceutical company that develops novel hydrogel-based therapeutics for the treatment of chronic pain conditions, including knee osteoarthritis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Relevium Medical Comparables
Compare Relevium Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DyAnsys, Inc. | 77% | |
| BioWave Corporation | 74% | |
| Medtronic | 66% |
Relevium Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 27, 2024 | ||||
| Series A | Jun 17, 2024 | ||||
| Accelerator | Aug 22, 2022 | ||||
| Seed | May 1, 2022 | ||||
| Grant | Jan 19, 2022 | ||||
Grant | Apr 22, 2021 |
Relevium Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Seed, Grant |
| Taighde Éireann – Research Ireland | Grant |
| Y Combinator | Seed, Accelerator |
| Enterprise Ireland | Accelerator, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 3, 2026
Grew 150% QoQ from 2 to 5 employees.
- May 15, 2026
Monthly visitors increased 48% MoM.
Relevium Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Relevium Medical's valuation, stock price, and market status.
Is Relevium Medical a public or private company?
Relevium Medical is a private company.
What is the current stock price of Relevium Medical?
Relevium Medical is a private company, so its shares have no public market price. Caplight tracks Relevium Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Relevium Medical worth (valuation)?
Valuation information for Relevium Medical is not publicly available.
Can I buy Relevium Medical stock?
Relevium Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Relevium Medical's last funding round?
Relevium Medical's most recent funding round was Grant on November 27, 2024.
Who are the main investors in Relevium Medical?
Key investors in Relevium Medical include European Innovation Council Fund, Taighde Éireann – Research Ireland, Y Combinator, Enterprise Ireland.
Will Relevium Medical IPO soon?
No public IPO plans have been announced for Relevium Medical.
How can I track Relevium Medical secondary market activity?
Caplight tracks bids, offers, and trades in Relevium Medical's shares on secondary markets.